B. Solomon

发表

Crizotinib in ROS 1-Rearranged Non – Small-Cell Lung Cancer

Jeffrey W. Clark, A. Iafrate, A. Shaw, 2014 .

Loss of telomerase activity during male germ cell differentiation.

B. Solomon, D. Djakiew, M. Dym, 1997, Endocrinology.

RepertoiresIncreased Allo- and Autoreactive T Cell Enhances Positive Selection, Leading to The Ability To Rearrange Dual TCRs

B. Solomon, C. Hsieh, P. Allen, 2014 .

A Laboratory-Friendly CTC Identification: Comparable Double-Immunocytochemistry with Triple-Immunofluorescence

B. Solomon, P. De, N. Dey, 2022, Cancers.

Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non–Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies

J. Blay, R. Schilsky, S. Ikeda, 2022, JCO precision oncology.

Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung

J. Blay, R. Schilsky, S. Ikeda, 2022, Therapeutic advances in medical oncology.

Crizotinib in ROS 1-Rearranged Non – Small-Cell Lung Cancer

Jeffrey W. Clark, A. Iafrate, A. Shaw, 2014 .

A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non‐small cell lung cancer

N. Girard, R. Schilsky, J. Lee, 2022, Cancer Medicine.

A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma

B. Solomon, H. Do, A. Dobrovic, 2014, Scientific Reports.